Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

Also called NCT01666041

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01666041
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01666041. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate
Condition
Hypertriglyceridemia
Intervention (Drug)
placebo
Intervention (Drug)
fenofibrate/omega
Intervention (Drug)
fenofibrate
Lead sponsor
Gachon University Gil Medical Center (class: other)

Record details

Record id
cardio:ct-nct01666041
Content hash
0e6098dae656190206073ad73194a7a20de69b58b2869411b9d390fa9b44e326